A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Last updated:
2026-09-12
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, 52-WEEK STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF BRENIPATIDE COMPARED WITH PLACEBO FOR THE TREATMENT OF ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Intervention/treatment:
BRENIPATIDE (LY3537031)
Medical condition:
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Protocol code:
J2S-MC-GZMV
Control number:
502286
Status:
Not yet recruiting
Approved:
June 16, 2026
Trial phase:
Phase 2
For more information:
ClinicalTrials.gov - NCT07759245
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
40 Years to 75 Years
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
Role
CONTACT
Phone:
1-317-615-4559
Name
Physicians interested in becoming principal investigators please contact
Role
CONTACT
Sponsor
ELI LILLY CANADA INC

Locations

C.I.C. Mauricie inc.
Trois-Rivières, G8T 7A1
Not yet recruiting
Name
Pierre-Alexandre Menard
Role
PRINCIPAL_INVESTIGATOR
Phone:
(519) 252-4448
Diex Recherche Inc. Division Sherbrooke Est
Sherbrooke, J1L 0K3
Not yet recruiting
Name
Jean-louis Aube
Role
PRINCIPAL_INVESTIGATOR
Phone:
4169449602
Dr. Syed Anees Medicine Professional Corporation
Windsor, N8X 1T3
Not yet recruiting
Name
Andreanne Cote
Role
CONTACT
Phone:
(519) 252-4448
Name
Syed Anees
Role
PRINCIPAL_INVESTIGATOR
Dynamic Drug Advancement
Ajax, L1S 2J5
Recruiting
Name
Colleen Maytham
Role
CONTACT
Phone:
3658859086
Name
George Philteos
Role
PRINCIPAL_INVESTIGATOR
Inspiration Research
Toronto, M5T 3A9
Recruiting
Name
Pierre-Alexandre Menard
Role
CONTACT
Phone:
4169449602
Name
Kenneth Chapman
Role
PRINCIPAL_INVESTIGATOR
Kelowna Health and Memory Centre
Kelowna, V1Y 5A8
Not yet recruiting
Name
Colleen Maytham
Role
PRINCIPAL_INVESTIGATOR
Did you find what you were looking for?

Contacts and resources